Status: Not yet recruiting
A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine
Evaluate the immunogenicity after boost vaccination with the live attenuated herpes zoster vaccine.
Participants needed: 100
Trial details
Phase: Early Phase 1Age: 50+Biological sex: AllType: InterventionalSponsor: Changchun BCHT Biotechnology Co.Updated: Aug 7, 2026
Eligibility criteria
Age ≥ 50 years old; [+3]
Subjects with immunodeficiency or immunosuppression caused by underlying disease... [+11]